Generic Medicines

Japanese PM Fumio Kishida announced plans to downgrade the legal status of COVID-19 to the equivalent of seasonal influenza in the spring

The state government has given priority to the health security of the people, the official said

The draft has also proposed to prohibit pre-grant oppositions, which means that India will not be able to stop challenges to weak/invalid patents until after they have been granted

Lupin on Wednesday said it has received approval from the USFDA for Formoterol Fumarate Inhalation Solution, used in treating symptoms of chronic obstructive pulmonary disease. The company has received approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of Mylan Specialty's Perforomist Inhalation Solution, the Mumbai-based drug maker said in a statement. As per IQVIA MAT June 2022 data, the medication had annual sales of around USD 282 million in the US market. Shares of Lupin ended 2.55 per cent down at Rs 677.65 apiece on the BSE on Wednesday.

Zydus Lifesciences on Monday said its subsidiary has received approval from the US health regulator to market antifungal Efinaconazole Topical solution

Prime Minister Modi will interact with Jan Aushadhi kendra owners and beneficiaries of the scheme on March 7 at 12:30 PM via video conferencing, according to the statement

With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott's Duphaston

Regulatory safeguards to ensure quality and efficacy of drugs are a necessary pre-condition for effective competition between generic and branded drugs

Concord has received approval from the US Food and Drug Administration (USFDA) to market the drug to prevent organ transplant rejection

According to IQVIA MAT April 2020 data, Albendazole tablets had an annual sales of around $34 million in the US, Lupin said

The product is a generic version of Novartis Pharmaceuticals Corporation's Myfortic delayed-release tablets in the same strengths, it added

Making essential drugs easily available is important in a country like India, which has less than one doctor per 1,000 people

Last week, Generico, which runs a network of pharmacies selling generic drugs, raised $14 million in a Series A funding round, led by venture capital firm Lightbox

Prime Minister Narendra Modi wants to defeat the doctor-pharmaceutical company nexus and make medicines affordable by making it compulsory to prescribe drugs in the generic name.But the good intentions may not give the desired results. Enforcement will not be easy given the shortage of drug inspectors.At an industry event at Surat last month Modi announced plans for a new law to make generic prescriptions mandatory. Parallelly the government is already initiating steps to push for generic prescriptions. In a recent communication to all the states, the Centre has asked states to make sure all physicians write generic names of drugs in a legible manner. Business Standard has reviewed the letter. The government has issued a draft amendment which will make it mandatory for companies to print generic names of the drug in a bolder font than the brand name on the packaging.But the government will face a difficult task in enforcing its decisions. Food and Drug Administration offices across ..

To make medicines cheaper, in another measure, govt added 200 drug formulations to NLEM list

Plan to make generics prescription compulsory has left pharma industry & medical fraternity jittery